Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer [Phase 2]
Phase 2 trial evaluating Sipuleucel-T with immediate versus delayed CTLA-4 blockade in prostate cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating cabazitaxel plus prednisone in metastatic hormone-resistant prostate cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease [Phase 2]
Phase 2 clinical trial update evaluating FACBC for detecting metastasis in high-risk prostate cancer patients with presumed localized diseas…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: [18F]PSMA-11 PET/CT Phase 3 Clinical Study [Phase 3]
Phase 3 clinical trial update for [18F]PSMA-11 PET/CT in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer [Phase 2]
Phase 2 trial comparing radiation-hormone therapy with docetaxel versus radiation-hormone therapy alone in high-risk localized prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy [Phase 2]
This Phase 2 clinical trial update investigates genetic and molecular factors associated with response to enzalutamide in prostate cancer, i…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Neoadjuvant BKM120 in High-risk Prostate Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating BKM120 in high-risk prostate cancer was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy
A completed clinical trial evaluating a consensus method to evaluate conformity of prescription for a chemotherapy regimen in prostate cance…
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer [Phase 3]
Phase 3 trial on using circulating tumor cell counts to optimize systemic therapy for metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer [NA]
Clinical trial update on MRI-guided SBRT with simultaneous integrated boost for prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy [Phase 2]
Phase 2 trial update of TRC105 in combination with abiraterone or enzalutamide in prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of enzalutamide and cabazitaxel for metastatic castration-resistant prostate cancer; results were…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating Gallium-68-HBED-CC-PSMA imaging in prostate cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of Liproca Depot Injection in patients with Prostate Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model
Clinical trial update describing a two-stage statistical model to model clinical failure in prostate cancer patients; results completed and …
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer [NA]
A completed clinical trial assessing hypofractionated accelerated radiotherapy for low-risk localized prostate cancer with results posted in…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer [Phase 2]
A multi-center Phase 2 randomized trial is investigating irreversible electroporation (IRE) for ablation of localized prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse [NA]
A completed clinical trial comparing ultrasound-based planning to CT-based planning for high-dose-rate prostate brachytherapy, with results …
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients [Phase 2, Phase 3]
Phase 2/3 trial of Gallium-68 PSMA-11 PET imaging in intermediate to high-risk prostate cancer patients undergoing preprostatectomy has comp…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients [Phase 4]
Phase 4 study of Eligard (leuprolide acetate) in hormone-dependent prostate cancer completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for abiraterone in metastatic castration-resistant prostate cancer, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Phase 4]
Phase 4 trial comparing immediate 9-month adjuvant hormone therapy with triporelin versus active surveillance after radical prostatectomy in…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases [Phase 4]
Phase 4 trial comparing 4-weekly versus 12-weekly administration of bone-targeted agents in patients with bone metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Prostate Adenocarcinoma TransCutaneous Hormones [Phase 3]
A Phase 3 clinical trial update for TransCutaneous Hormones in prostate adenocarcinoma, with listed conditions including anemia, cardiovascu…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer [Phase 2]
Phase II trial comparing PAP Plus GM-CSF versus GM-CSF alone in non-metastatic prostate cancer completed with posted results.